Zobrazeno 1 - 10 of 30 pro vyhledávání: '"Göran Hasselgren"'
1
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months
Autor: Rolf Carlsson, Thomas L. Venables, Göran Hasselgren, Karna Dev Bardhan, Kevin P J O'Kane, David Armstrong, Mustafa H. Giaffer, Samuel Chen, Nicholas J. Talley, J. R. B. Green
Publikováno v: European Journal of Gastroenterology & Hepatology. 14:857-863
On-demand therapy may offer an effective approach to the long-term management of gastro-oesophageal reflux disease (GORD) without oesophagitis.To examine the efficacy of the novel proton pump inhibitor esomeprazole as on-demand therapy in endoscopy-n
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414d1adc6dd15671f1ce87512d82395a
https://doi.org/10.1097/00042737-200208000-00008
Zobrazit plný text záznamu
2
[Untitled]
Autor: Kerstin Röhss, Hans Hedenström, Göran Hasselgren
Publikováno v: Digestive Diseases and Sciences. 47:954-958
Maintenance of intragastric pH > 4 is vital for effective management of gastroesophageal reflux disease (GERD). Esomeprazole 40 mg, the first proton pump inhibitor developed as an optical isomer, demonstrates improved acid inhibition over omeprazole
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::471d8ba64a1d8b32e83641ef7fe4cfd0
https://doi.org/10.1023/a:1015009300955
Zobrazit plný text záznamu
3
Pharmacokinetics of Omeprazole Given by Continuous Intravenous Infusion to Patients with Varying Degrees of Hepatic Dysfunction
Autor: Josep M. Piqué, Faust Feu, Gloria de Prada, Kerstin Röhss, Göran Hasselgren
Publikováno v: Clinical Pharmacokinetics. 41:999-1004
To examine the pharmacokinetics of omeprazole during intravenous infusion in patients with varying degrees of liver dysfunction (Child-Pugh categories A to C).Nonblinded single-period study.Thirteen patients, five males and eight females with a mean
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3822752d983a5a0022c2d55e8e868056
https://doi.org/10.2165/00003088-200241120-00004
Zobrazit plný text záznamu
4
One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease
Autor: Ann Larko, Zbigniew Bartuzi, Göran Hasselgren, Michael Wrangstadh, Dariusz Kleczkowski, Zsolt Tulassay, Petr Dite, Janusz Rudzinski, Andrzej Kryszewski
Publikováno v: European Journal of Gastroenterology & Hepatology. 13:1457-1465
Proton pump inhibitor (PPI) monotherapy is commonly continued for 3 weeks after Helicobacter pylori eradication with PPI-based triple therapy regimens to ensure duodenal ulcer (DU) healing. This randomized, double-blind, multicentre study evaluated w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dccfd711d7429f98dea1f88dbe26aacd
https://doi.org/10.1097/00042737-200112000-00009
Zobrazit plný text záznamu
5
Drug Interaction Studies with Esomeprazole, the (S)-Isomer of Omeprazole
Autor: Göran Hasselgren, Tommy B. Andersson, Mohammed Hassan-Alin, Kerstin Röhss
Publikováno v: Clinical Pharmacokinetics. 40:523-537
Esomeprazole, the (S)-isomer of omeprazole, is the first proton pump inhibitor (PPI) developed as a single isomer for the treatment of patients with acid related diseases. Because of the extensive use of PPIs, the documentation of the potential for d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce22d94e710c5e71ea09f7937bbb938a
https://doi.org/10.2165/00003088-200140070-00004
Zobrazit plný text záznamu
6
Pharmacokinetic Study of Esomeprazole in the Elderly
Autor: Tommy B. Andersson, Kerstin Röhss, Mohammed Hassan-Alin, Göran Hasselgren, Catharina Claar-Nilsson
Publikováno v: Clinical Pharmacokinetics. 40:145-150
Esomeprazole is the first proton pump inhibitor to be developed as an optical isomer for the treatment of patients with acid-related diseases. The aim of this study was to examine the pharmacokinetics and tolerability of esomeprazole in the elderly,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64e88b6c6796d344faa8b24ff97a0d9
https://doi.org/10.2165/00003088-200140020-00006
Zobrazit plný text záznamu
7
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease
Autor: C. M. De Argila, L. Göthe, M. Wrangstadh, A Stubberöd, Jean-Charles Delchier, S Veldhuyzen van Zanten, Joachim Labenz, Tore Lind, P. Sinclair, H.-C. Treichel, Karsten Lauritsen, Alan Cockeram, Göran Hasselgren
Publikováno v: Alimentary Pharmacology & Therapeutics. 14:1605-1611
Background: Esomeprazole is the first proton pump inhibitor to be developed as an optical isomer for the treatment of acid-related diseases. Methods: Four hundred and forty eight duodenal ulcer patients with Helicobacter pylori infection, confirmed b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1edea00ed4fa74a68e344cb65717438
https://doi.org/10.1046/j.1365-2036.2000.00911.x
Zobrazit plný text záznamu
8
Studies in Healthy Volunteers do not Show any Electrocardiographic Effects with Esomeprazole
Autor: Göran Hasselgren, Mohammad Niazi, Catharina Claar-Nilsson, Birgitta Hasselgren, Elisabeth Svernhage
Publikováno v: Clinical Drug Investigation. 20:425-431
Objectives: Esomeprazole is the first proton pump inhibitor developed as an optical isomer. The aim of this study was to assess the potential effects of this agent on the electrocardiogram (ECG) in healthy volunteers. Study Participants and Methods:
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bcbe47507f627652b41118e0787e9c36
https://doi.org/10.2165/00044011-200020060-00005
Zobrazit plný text záznamu
9
Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease
Autor: Göran Hasselgren, Kylebäck A, Tore Lind, Tommy B. Andersson, Holmberg J, A Jonsson, L Rydberg, Kerstin Röhss
Publikováno v: Alimentary Pharmacology & Therapeutics. 14:861-867
Background: Esomeprazole (Nexium) is a new proton pump inhibitor for the treatment of acid-related diseases. Methods: In this double-blind crossover study, 38 patients with gastro-oesophageal reflux disease (GERD) symptoms were randomized to esomepra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::194c5ae3df3d0572ec48707156d4b3c5
https://doi.org/10.1046/j.1365-2036.2000.00813.x
Zobrazit plný text záznamu
10
Replacement of the Os Trapezium by Polyurethane Implants
Autor: K. Herrlin, Jan Westermark, Göran Hasselgren, Christer Sollerman
Publikováno v: Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 27:217-221
Twenty-five patients with arthrosis of the first carpometacarpal joint had the os trapezium replaced by a polyurethane implant (TecoflexR), and the results were evaluated after three years (range 28-47 months). There were three failures in which the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ddce2410ca7c6a22b853c3b9260cad4
https://doi.org/10.3109/02844319309078114
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje